annual cost of goods sold:
$11.56B+$906.05M(+8.50%)Summary
- As of today (May 21, 2025), GSK annual cost of goods sold is $11.56 billion, with the most recent change of +$906.05 million (+8.50%) on December 31, 2024.
- During the last 3 years, GSK annual cost of goods sold has risen by +$333.50 million (+2.97%).
- GSK annual cost of goods sold is now -23.66% below its all-time high of $15.15 billion, reached on December 31, 2019.
Performance
GSK Cost of goods sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cost of goods sold:
$2.44B-$837.38M(-25.56%)Summary
- As of today (May 21, 2025), GSK quarterly cost of goods sold is $2.44 billion, with the most recent change of -$837.38 million (-25.56%) on March 31, 2025.
- Over the past year, GSK quarterly cost of goods sold has dropped by -$59.78 million (-2.39%).
- GSK quarterly cost of goods sold is now -68.52% below its all-time high of $7.75 billion, reached on December 31, 2003.
Performance
GSK quarterly cost of goods sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM cost of goods sold:
$11.51B-$59.78M(-0.52%)Summary
- As of today (May 21, 2025), GSK TTM cost of goods sold is $11.51 billion, with the most recent change of -$59.78 million (-0.52%) on March 31, 2025.
- Over the past year, GSK TTM cost of goods sold has increased by +$714.65 million (+6.62%).
- GSK TTM cost of goods sold is now -26.55% below its all-time high of $15.67 billion, reached on March 31, 2020.
Performance
GSK TTM cost of goods sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cost of goods sold Formula
COGS = Beginning Inventory + Purchases − Ending Inventory
GSK Cost of goods sold Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8.5% | -2.4% | +6.6% |
| 3 y3 years | +3.0% | -33.1% | -8.4% |
| 5 y5 years | -23.7% | -40.5% | -26.6% |
GSK Cost of goods sold Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -2.3% | +8.5% | -33.1% | +3.3% | -11.4% | +12.2% |
| 5 y | 5-year | -23.7% | +13.6% | -40.5% | +406.0% | -26.6% | +47.8% |
| alltime | all time | -23.7% | +710.4% | -68.5% | +169.8% | -26.6% | +2272.9% |
GSK Cost of goods sold History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $2.44B(-25.6%) | $11.51B(-0.5%) |
| Dec 2024 | $11.56B(+8.5%) | $3.28B(+5.0%) | $11.57B(+2.4%) |
| Sep 2024 | - | $3.12B(+16.5%) | $11.30B(+2.2%) |
| Jun 2024 | - | $2.68B(+7.1%) | $11.06B(+2.4%) |
| Mar 2024 | - | $2.50B(-16.8%) | $10.80B(+1.3%) |
| Dec 2023 | $10.66B(-9.9%) | $3.00B(+4.4%) | $10.66B(+3.6%) |
| Sep 2023 | - | $2.88B(+19.0%) | $10.29B(+0.2%) |
| Jun 2023 | - | $2.42B(+2.4%) | $10.26B(-3.0%) |
| Mar 2023 | - | $2.36B(-10.3%) | $10.58B(-10.8%) |
| Dec 2022 | $11.83B(+5.4%) | $2.63B(-7.7%) | $11.86B(-8.6%) |
| Sep 2022 | - | $2.85B(+4.2%) | $12.99B(+0.6%) |
| Jun 2022 | - | $2.74B(-25.0%) | $12.91B(+2.8%) |
| Mar 2022 | - | $3.65B(-2.9%) | $12.57B(+1.8%) |
| Dec 2021 | $11.23B(+10.4%) | $3.75B(+35.1%) | $12.34B(+58.4%) |
| Sep 2021 | - | $2.78B(+16.4%) | $7.79B(-10.9%) |
| Jun 2021 | - | $2.39B(-30.2%) | $8.74B(-6.9%) |
| Mar 2021 | - | $3.42B(-529.0%) | $9.39B(-6.8%) |
| Dec 2020 | $10.18B(-32.8%) | -$796.94M(-121.4%) | $10.07B(-33.1%) |
| Sep 2020 | - | $3.73B(+22.8%) | $15.05B(-1.8%) |
| Jun 2020 | - | $3.04B(-25.9%) | $15.32B(-2.2%) |
| Mar 2020 | - | $4.10B(-2.0%) | $15.67B(+3.6%) |
| Dec 2019 | $15.15B(+10.9%) | $4.18B(+4.6%) | $15.13B(+3.1%) |
| Sep 2019 | - | $4.00B(+18.0%) | $14.68B(+4.0%) |
| Jun 2019 | - | $3.39B(-4.8%) | $14.12B(+1.7%) |
| Mar 2019 | - | $3.56B(-4.7%) | $13.88B(+1.7%) |
| Dec 2018 | $13.66B(+2.3%) | $3.74B(+8.8%) | $13.64B(+2.6%) |
| Sep 2018 | - | $3.43B(+9.1%) | $13.30B(-0.3%) |
| Jun 2018 | - | $3.15B(-5.3%) | $13.34B(-1.5%) |
| Mar 2018 | - | $3.32B(-2.1%) | $13.54B(+1.6%) |
| Dec 2017 | $13.35B(+6.1%) | $3.40B(-2.2%) | $13.33B(+2.2%) |
| Sep 2017 | - | $3.47B(+3.7%) | $13.05B(+1.2%) |
| Jun 2017 | - | $3.35B(+7.6%) | $12.89B(+2.4%) |
| Mar 2017 | - | $3.11B(-0.1%) | $12.60B(+0.5%) |
| Dec 2016 | $12.59B(-7.0%) | $3.12B(-6.1%) | $12.54B(-5.6%) |
| Sep 2016 | - | $3.32B(+8.7%) | $13.28B(-0.7%) |
| Jun 2016 | - | $3.05B(-0.1%) | $13.37B(-0.2%) |
| Mar 2016 | - | $3.05B(-20.8%) | $13.39B(-1.0%) |
| Dec 2015 | $13.53B(+12.1%) | $3.85B(+12.9%) | $13.53B(+5.0%) |
| Sep 2015 | - | $3.42B(+11.2%) | $12.88B(+2.9%) |
| Jun 2015 | - | $3.07B(-3.7%) | $12.52B(+1.4%) |
| Mar 2015 | - | $3.19B(-0.7%) | $12.35B(+2.5%) |
| Dec 2014 | $12.07B(-10.1%) | $3.21B(+5.1%) | $12.05B(-6.8%) |
| Sep 2014 | - | $3.05B(+5.4%) | $12.92B(-1.7%) |
| Jun 2014 | - | $2.90B(+0.5%) | $13.14B(-1.0%) |
| Mar 2014 | - | $2.88B(-29.5%) | $13.28B(-1.4%) |
| Dec 2013 | $13.43B(+7.0%) | $4.09B(+24.9%) | $13.46B(+6.7%) |
| Sep 2013 | - | $3.27B(+8.1%) | $12.61B(-0.2%) |
| Jun 2013 | - | $3.03B(-1.3%) | $12.64B(-1.1%) |
| Mar 2013 | - | $3.07B(-5.2%) | $12.77B(+1.7%) |
| Dec 2012 | $12.56B(+2.4%) | $3.24B(-1.8%) | $12.56B(+1.4%) |
| Sep 2012 | - | $3.30B(+4.2%) | $12.38B(-0.4%) |
| Jun 2012 | - | $3.17B(+10.9%) | $12.44B(+2.6%) |
| Mar 2012 | - | $2.86B(-6.8%) | $12.12B(-1.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | $12.26B(+0.7%) | $3.06B(-8.7%) | $12.26B(-5.4%) |
| Sep 2011 | - | $3.35B(+17.9%) | $12.96B(+3.2%) |
| Jun 2011 | - | $2.85B(-5.1%) | $12.56B(+3.1%) |
| Mar 2011 | - | $3.00B(-20.3%) | $12.19B(-0.4%) |
| Dec 2010 | $12.18B(+5.3%) | $3.76B(+27.5%) | $12.23B(+2.5%) |
| Sep 2010 | - | $2.95B(+19.5%) | $11.93B(+0.2%) |
| Jun 2010 | - | $2.47B(-18.9%) | $11.90B(-1.3%) |
| Mar 2010 | - | $3.04B(-12.1%) | $12.06B(+4.1%) |
| Dec 2009 | $11.56B(-2.6%) | $3.46B(+18.4%) | $11.58B(+3.6%) |
| Sep 2009 | - | $2.92B(+11.2%) | $11.18B(-0.7%) |
| Jun 2009 | - | $2.63B(+2.3%) | $11.26B(-3.1%) |
| Mar 2009 | - | $2.57B(-16.0%) | $11.61B(-1.0%) |
| Dec 2008 | $11.86B(+13.8%) | $3.06B(+1.7%) | $11.73B(-0.7%) |
| Sep 2008 | - | $3.01B(+0.8%) | $11.81B(+4.6%) |
| Jun 2008 | - | $2.98B(+11.0%) | $11.29B(+5.4%) |
| Mar 2008 | - | $2.69B(-14.2%) | $10.72B(+2.6%) |
| Dec 2007 | $10.43B(+12.9%) | $3.13B(+25.8%) | $10.44B(+3.6%) |
| Sep 2007 | - | $2.49B(+3.5%) | $10.08B(+2.0%) |
| Jun 2007 | - | $2.41B(-0.2%) | $9.88B(+2.0%) |
| Mar 2007 | - | $2.41B(-12.9%) | $9.68B(+4.6%) |
| Dec 2006 | $9.23B(+6.6%) | $2.77B(+20.9%) | $9.26B(+5.7%) |
| Sep 2006 | - | $2.29B(+3.5%) | $8.76B(+2.0%) |
| Jun 2006 | - | $2.21B(+11.4%) | $8.58B(+0.8%) |
| Mar 2006 | - | $1.99B(-12.4%) | $8.51B(-1.7%) |
| Dec 2005 | $8.67B(+8.5%) | $2.27B(+7.0%) | $8.66B(+0.9%) |
| Sep 2005 | - | $2.12B(-1.0%) | $8.58B(+1.3%) |
| Jun 2005 | - | $2.14B(+0.4%) | $8.48B(+3.1%) |
| Mar 2005 | - | $2.13B(-2.8%) | $8.22B(+2.9%) |
| Dec 2004 | $7.99B(+7.6%) | $2.19B(+9.0%) | $7.99B(-41.0%) |
| Sep 2004 | - | $2.01B(+6.7%) | $13.55B(+68.5%) |
| Jun 2004 | - | $1.89B(-0.8%) | $8.04B(+2.3%) |
| Mar 2004 | - | $1.90B(-75.5%) | $7.86B(+1.3%) |
| Dec 2003 | $7.42B(+7.1%) | $7.75B(-321.6%) | $7.76B(+292.1%) |
| Sep 2003 | - | -$3.50B(-304.9%) | $1.98B(-72.6%) |
| Jun 2003 | - | $1.71B(-5.1%) | $7.22B(+1.2%) |
| Mar 2003 | - | $1.80B(-8.7%) | $7.14B(+3.0%) |
| Dec 2002 | $6.93B(+8.3%) | $1.97B(+12.6%) | $6.94B(+5.1%) |
| Sep 2002 | - | $1.75B(+7.8%) | $6.60B(+1.5%) |
| Jun 2002 | - | $1.62B(+1.9%) | $6.50B(+0.7%) |
| Mar 2002 | - | $1.59B(-2.5%) | $6.46B(+1.1%) |
| Dec 2001 | $6.39B(+6.5%) | $1.63B(-1.2%) | $6.39B(-0.2%) |
| Sep 2001 | - | $1.65B(+4.7%) | $6.41B(+4.2%) |
| Jun 2001 | - | $1.58B(+3.6%) | $6.15B(+0.4%) |
| Mar 2001 | - | $1.53B(-7.3%) | $6.12B(+2.3%) |
| Dec 2000 | $6.01B(-14.4%) | $1.65B(+18.1%) | $5.99B(+37.9%) |
| Sep 2000 | - | $1.39B(-10.4%) | $4.34B(+47.3%) |
| Jun 2000 | - | $1.56B(+11.9%) | $2.95B(+53.4%) |
| Mar 2000 | - | $1.39B(+162.0%) | $1.92B(+262.0%) |
| Dec 1999 | $7.01B(+173.9%) | - | - |
| Jun 1999 | - | $530.79M(+9.4%) | $530.79M(+9.4%) |
| Dec 1998 | $2.56B(+79.5%) | - | - |
| Jun 1998 | - | $485.13M | $485.13M |
| Jun 1995 | $1.43B | - | - |
FAQ
- What is GSK annual cost of goods sold?
- What is the all time high annual cost of goods sold for GSK?
- What is GSK annual cost of goods sold year-on-year change?
- What is GSK quarterly cost of goods sold?
- What is the all time high quarterly cost of goods sold for GSK?
- What is GSK quarterly cost of goods sold year-on-year change?
- What is GSK TTM cost of goods sold?
- What is the all time high TTM cost of goods sold for GSK?
- What is GSK TTM cost of goods sold year-on-year change?
What is GSK annual cost of goods sold?
The current annual cost of goods sold of GSK is $11.56B
What is the all time high annual cost of goods sold for GSK?
GSK all-time high annual cost of goods sold is $15.15B
What is GSK annual cost of goods sold year-on-year change?
Over the past year, GSK annual cost of goods sold has changed by +$906.05M (+8.50%)
What is GSK quarterly cost of goods sold?
The current quarterly cost of goods sold of GSK is $2.44B
What is the all time high quarterly cost of goods sold for GSK?
GSK all-time high quarterly cost of goods sold is $7.75B
What is GSK quarterly cost of goods sold year-on-year change?
Over the past year, GSK quarterly cost of goods sold has changed by -$59.78M (-2.39%)
What is GSK TTM cost of goods sold?
The current TTM cost of goods sold of GSK is $11.51B
What is the all time high TTM cost of goods sold for GSK?
GSK all-time high TTM cost of goods sold is $15.67B
What is GSK TTM cost of goods sold year-on-year change?
Over the past year, GSK TTM cost of goods sold has changed by +$714.65M (+6.62%)